Comparative efficacy of glucose-lowering drugs on liver steatosis as assessed by means of magnetic resonance imaging in patients with type 2 diabetes mellitus: systematic review and network meta-analysis

CONCLUSIONS: GLP-1 RAs and SGLT-2 inhibitors seem to be the most efficacious glucose-lowering drugs for liver steatosis in patients with T2D. Assessment of their efficacy on NAFLD in patients irrespective of presence of T2D is encouraged.PMID:37770761 | DOI:10.1007/s42000-023-00493-z

Source: Hormones - September 28, 2023 Category: Endocrinology Authors: Konstantinos Malandris Stylianos Papandreou Ioannis Avgerinos Thomas Karagiannis Paschalis Paschos Theodoros Michailidis Aris Liakos Eleni Bekiari Emmanouil Sinakos Apostolos Tsapas Source Type: research